Difficulty: Medium
Average Score: 76%
Practice
Which of the following drugs is most likely to cause hypoglycemia when used as monotherapy in the treatment of type 2 diabetes?
Correct answer
B
Rationale
In the context of pharmacological management of type 2 diabetes, the correct answer to the question is option B) Glyburide. Glyburide belongs to the class of sulfonylureas, which work by stimulating insulin release from the pancreas. This mechanism of action increases the risk of hypoglycemia because it can lead to excessive insulin production, especially if the patient is not eating adequately or if there is a mismatch between insulin release and glucose levels.
Option A) Acarbose is an alpha-glucosidase inhibitor that slows carbohydrate digestion and absorption, which generally does not cause hypoglycemia as it does not directly affect insulin levels.
Option C) Metformin is a biguanide that primarily works by decreasing glucose production in the liver and improving insulin sensitivity in peripheral tissues. It does not typically cause hypoglycemia as it does not directly increase insulin secretion.
Option D) Miglitol is also an alpha-glucosidase inhibitor similar to Acarbose and is not associated with a high risk of hypoglycemia due to its mechanism of action.
Educationally, understanding the mechanisms of action of different antidiabetic drugs is crucial for healthcare professionals to make informed decisions when managing patients with type 2 diabetes. Knowing which drugs are more likely to cause hypoglycemia can help in individualizing treatment plans and monitoring for adverse effects, ultimately improving patient outcomes.
Option A) Acarbose is an alpha-glucosidase inhibitor that slows carbohydrate digestion and absorption, which generally does not cause hypoglycemia as it does not directly affect insulin levels.
Option C) Metformin is a biguanide that primarily works by decreasing glucose production in the liver and improving insulin sensitivity in peripheral tissues. It does not typically cause hypoglycemia as it does not directly increase insulin secretion.
Option D) Miglitol is also an alpha-glucosidase inhibitor similar to Acarbose and is not associated with a high risk of hypoglycemia due to its mechanism of action.
Educationally, understanding the mechanisms of action of different antidiabetic drugs is crucial for healthcare professionals to make informed decisions when managing patients with type 2 diabetes. Knowing which drugs are more likely to cause hypoglycemia can help in individualizing treatment plans and monitoring for adverse effects, ultimately improving patient outcomes.